faCellitate
Signal active
Organization
Contact Information
Overview
faCellitate develops polymeric platforms that aim at supporting cancer and stem cell research, drug discovery, toxicology, and tissue engineering. The platform facilitates cellular interaction, significantly improving cell culture in biological research.
About
Industries
Biotechnology
Founded
2019
Employees
11-50
Headquarters locations
Mannheim, Baden-Wurttemberg, Germany, Europe
Social
Profile Resume
faCellitate headquartered in Europe, operates in the Biotechnology sector. The company focuses on Biotechnology and has secured $14.8M in funding across 4 round(s). With a team of 11-50 employees, faCellitate is actively contributing to advancements in Biotechnology. Their latest funding round, Seed Round - faCellitate, raised $3.7M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
1
Investors
6
Lead Investors
0
Total Funding Amount
$3.7M
Details
1
faCellitate has raised a total of $3.7M in funding over 1 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2022 | Seed | 3.7M |
Investors
faCellitate is funded by 7 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| faCellitate | - | FUNDING ROUND - faCellitate | 3.7M |
| R3 | - | FUNDING ROUND - R3 | 3.7M |
| faCellitate | - | FUNDING ROUND - faCellitate | 3.7M |
| Chemovator | - | FUNDING ROUND - Chemovator | 3.7M |